TUSC3 and gastric cancer: The present study, for the first time, reported the involvement of the LncRNA MIR503HG/miR-224-5p/TUSC3 signaling cascade in regulating GC pathogenesis, and the potential underlying mechanisms had also been uncovered, which provided evidences to support that this axis could be used as potential biomarkers for GC diagnosis and treatment.